Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a significant performance update of its chemistry for the Evercode™ Whole Transcriptome products.
With substantial gains in transcript and gene detection alongside a more robust assay, the newly released chemistry for the Evercode™ Whole Transcriptome products improves upon the previous version in performance areas most relevant to researchers. Over 400 labs around the world have already embraced the Parse Biosciences Evercode combinatorial barcoding technology and its unmatched scale and flexibility for single cell RNA-Seq (scRNA-Seq).
